Capital Ordinaire Changement Date
AbbVie USD 1.77B 608K 2026-06
Actinium Pharmaceuticals USD 31.2M 0 2025-09
Amgen USD 541M 0 2026-09
Bioline Rx USD 2.62B 10.16M 2026-06
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Pfizer USD 5.7B 1000K 2026-09